Certain STING agonists, including cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) and structure-mimicking cyclic dinucleotides (CDNs) are being tested to treat cancers in clinic [25]. This evidence concerns the gene STING1 and cancer.